GENEVA, Aug. 14 -- FARADAY PHARMACEUTICALS, INC. filed a patent application (US2025/025447) for “S-OXPRENOLOL FOR PRESERVING MUSCLE MASS, BONE DENSITY, AND CARDIAC FUNCTION IN WEIGHT LOSS TREATMENTS”. With publication no. WO/2025/222169, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 31/138

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....